BCIQ Profiles

Company Profile Report

Spotlight co-founder uses CRISPR screen to ID T cell regulator genes for cancer

Spotlight Therapeutics Inc. (Hayward, Calif.) co-founder Alexander Marson and colleagues at University of California San Francisco developed a CRISPR-based screen to identify genes that control T cell replication and immunosuppression, and used the results to design a cancer immunotherapy

Read the full 393 word article

How to gain access

Continue reading with a
two-week free trial.